BN

Balaji Narayanrao Asegaonkar

Active Director Director DIN 03040990
DIN 03040990 First appointment Jun 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Jun 2010
Shareholding value •••• Premium profile

About Balaji Narayanrao Asegaonkar

Data last updated:

Balaji Narayanrao Asegaonkar is a Director at Ozone Anaesthesia & Critical Care Private Limited (since 2010) and Director at Geranto 360 Care Private Limited (since 2022). The companies operate in Healthcare and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹8.26 Cr; the largest is Ozone Anaesthesia & Critical Care Private Limited at ₹8.20 Cr (FY 2024). Earlier, Balaji Narayanrao Asegaonkar was a Director at Ciigma Health Foundation (2014–2020) and Designated Partner at Sb Ventures Llp (from 2017).

DIN 03040990
Primary Designation Director
Industry Healthcare
First Appointment 09 Jun 2010
Oldest Company Age 16 yrs
Largest company Ozone Anaesthesia & Critical Care Private Limited · ₹8.20 Cr (FY 2024)
Combined revenue ₹8.26 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20102010₹8.20 Cr (FY 2024)Active
Geranto 360 Care Private Limited U85300MH2022PTC378079
Director08 Mar 20222022₹6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ciigma Health Foundation U74999MH2014NPL257471
Director22 Aug 20142014₹6,796 (FY 2025)Active
Sb Ventures Llp AAI-3007
Designated Partner18 Jan 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ozone Anaesthesia & Critical Care Private Limited
Geranto 360 Care Private Limited
Sb Ventures Llp
Ciigma Health Foundation
Premium access

Shareholding and investment profile for Balaji Narayanrao Asegaonkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balaji Narayanrao Asegaonkar

Balaji Narayanrao Asegaonkar currently holds 2 directorships: Ozone Anaesthesia & Critical Care Private Limited (Director, since 09 Jun 2010, revenue ₹8.20 Cr (FY 2024)); Geranto 360 Care Private Limited (Director, since 08 Mar 2022, revenue ₹6 Lakh (FY 2025)).

Balaji Narayanrao Asegaonkar was first appointed on 09 Jun 2010 as Director at Ozone Anaesthesia & Critical Care Private Limited. The most recent appointment on record is 08 Mar 2022 at Geranto 360 Care Private Limited.

The 2 current companies of Balaji Narayanrao Asegaonkar that report revenue have a combined latest revenue of ₹8.26 Cr: Ozone Anaesthesia & Critical Care Private Limited ₹8.20 Cr (FY 2024); Geranto 360 Care Private Limited ₹6 Lakh (FY 2025).

Balaji Narayanrao Asegaonkar held 2 earlier board appointments: Ciigma Health Foundation (Director, 22 Aug 2014 to 11 Feb 2020); Sb Ventures Llp (Designated Partner, from 18 Jan 2017).

The current boards of Balaji Narayanrao Asegaonkar's companies include Chhaya Vijay Daunde (Ozone Anaesthesia & Critical Care Private Limited), Dattatraya Sopanrao Khade (Ozone Anaesthesia & Critical Care Private Limited), Narayan Devidasrao Asegaonkar (Ozone Anaesthesia & Critical Care Private Limited), Pramod Uddhavrao Apsingkar (Ozone Anaesthesia & Critical Care Private Limited), Sujeet Dattatraya Khade (Ozone Anaesthesia & Critical Care Private Limited), Uddhavrao Baburao Apasingekar (Ozone Anaesthesia & Critical Care Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available